Farhangi Mahdieh Abbasalizad, Nikniaz Leila, Nikniaz Zeinab, Dehghan Parvin
Research Center for Evidence Based Medicine, Health Management and Safety Promotion Research Institute, Tabriz University of Medical Sciences, Attar Neyshabouri Street, 5166614766 Tabriz, Iran.
Tabriz Health Services Management Research Center, Health Management and Safety Promotion Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Public Health Nutr. 2020 Jun;23(8):1362-1380. doi: 10.1017/S1368980019003070. Epub 2019 Nov 11.
In the current meta-analysis, we aimed to systematically review and summarize eligible studies for the association between dietary inflammatory index (DII) and blood pressure, hypertension (HTN) and glucose homeostasis biomarkers.
DESIGN/SETTING: In a systematic search of PubMed, Scopus and Google Scholar electronic databases up to February 2019, relevant studies were included in the literature review. Observational studies evaluating the association between DII and HTN, hyperglycaemia, systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting blood glucose (FBG), insulin, homeostatic model assessment of insulin resistance (HOMA-IR) and glycated Hb (HbA1c) were included.
Not applicable.
Total numbers of studies were as follows: OR for DII and HTN (n 12), OR for DII and hyperglycaemia (n 9), HTN prevalence (n 9), mean (sd) of SBP and DII (n 12), mean (sd) of DBP and DII (n 10), mean (sd) of FBS and DII (n 13), mean (sd) of HbA1c and DII (n 3), mean (sd) of insulin and DII (n 6), mean (sd) of HOMA-IR and DII (n 7). Higher DII scores were associated with higher odds of HTN (OR = 1·13; 95 % CI 1·01, 1·27; P < 0·001), SBP (weighted mean difference (WMD) = 1·230; 95 % CI 0·283, 2·177; P = 0·011), FBS (WMD = 1·083; 95 % CI 0·099, 2·068; P = 0·031), insulin (WMD = 0·829; 95 % CI 0·172, 1·486; P = 0·013), HbA1c (WMD = 0·615; 95 % CI 0·268, 0·961; P = 0·001) and HOMA-IR (WMD = 0·192; 95 % CI 0·023, 0·361; P = 0·026) values compared with lowest DII categories.
Lower inflammatory content of diets for prevention of cardiovascular risk factors is recommended.
在当前的荟萃分析中,我们旨在系统回顾和总结关于饮食炎症指数(DII)与血压、高血压(HTN)和血糖稳态生物标志物之间关联的合格研究。
设计/背景:在对截至2019年2月的PubMed、Scopus和谷歌学术电子数据库进行系统检索时,相关研究被纳入文献综述。纳入了评估DII与HTN、高血糖、收缩压(SBP)、舒张压(DBP)、空腹血糖(FBG)、胰岛素、胰岛素抵抗稳态模型评估(HOMA-IR)和糖化血红蛋白(HbA1c)之间关联的观察性研究。
不适用。
研究总数如下:DII与HTN的比值比(n = 12)、DII与高血糖的比值比(n = 9)、HTN患病率(n = 9)、SBP与DII的均值(标准差)(n = 12)、DBP与DII的均值(标准差)(n = 10)、FBS与DII的均值(标准差)(n = 13)、HbA1c与DII的均值(标准差)(n = 3)、胰岛素与DII的均值(标准差)(n = 6)、HOMA-IR与DII的均值(标准差)(n = 7)。与最低DII类别相比,较高的DII分数与HTN(比值比=1.13;95%置信区间1.01, 1.27;P<0.001)、SBP(加权均值差(WMD)=1.230;95%置信区间0.283, 2.177;P = 0.011)、FBS(WMD = 1.083;95%置信区间0.099, 2.068;P = 0.031)、胰岛素(WMD = 0.829;95%置信区间0.172, 1.486;P = 0.013)、HbA1c(WMD = 0.615;95%置信区间0.268, 0.961;P = 0.001)和HOMA-IR(WMD = 0.192;95%置信区间0.023, 0.361;P = 0.026)值的较高几率相关。
建议降低饮食中的炎症成分以预防心血管危险因素。